Literature DB >> 22199233

Proteome expression and carbonylation changes during Trypanosoma cruzi infection and Chagas disease in rats.

Jian-Jun Wen1, Nisha Jain Garg.   

Abstract

Inflammation and oxidative stress, elicited by Trypanosoma cruzi infection, are important pathologic events during progressive Chagasic cardiomyopathy. In this study, we infected Sprague-Dawley rats with T. cruzi, and treated with phenyl-α-tert-butylnitrone (PBN-antioxidant) and/or benznidazole (BZ-anti-parasite). We employed two-dimensional gel electrophoresis/mass spectrometry to investigate (a) the plasma proteomic changes associated with infection and disease development, and (b) the beneficial effects of PBN and BZ in controlling the disease-associated plasma profile. Matrix-assisted laser desorption ionization/time of flight (MALDI-TOF) tandem MS (MS/MS) analysis of differentially expressed (total 146) and oxidized (total 48) protein spots yielded 92 unique proteins. Our data showed that treatment with PBN and BZ restored the differential expression of 65% and 30% of the disease-associated proteins to normal level, respectively, and PBN prevented development of oxidative adducts on plasma proteins. Western blotting to detect dinitrophenyl-derivatized carbonyl-proteins revealed plasma proteins were maximally oxidized during acute infection. Functional and disease/disorder analyses allocated a majority of the differentially expressed and oxidized proteins into inflammation/immunity and lipid metabolism categories and to molecular pathways associated with heart disease (e.g. cardiac infarction, contractile dysfunction, hypertrophy, and hypertension) in chagasic rats, and to curative pathways (e.g. ROS scavenging capacity, immune regulation) in infected rats treated with PBN and/or BZ. We validated the two-dimensional gel electrophoresis results by Western blotting, and demonstrated that the disease-associated increased expression of gelsolin and vimentin and release of cardiac MYL2 in the plasma of chagasic rats was returned to control level by PBN/BZ treatment. Increased plasma levels of gelsolin, MYL2 and vimentin were directly correlated with the severity of cardiac disease in human chagasic patients. Together, these results demonstrate the plasma oxidative and inflammatory response profile, and plasma detection of cardiac proteins parallels the pathologic events contributing to Chagas disease development, and is of potential utility in diagnosing disease severity and designing suitable therapy for management of human chagasic patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22199233      PMCID: PMC3322564          DOI: 10.1074/mcp.M111.010918

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  61 in total

1.  Gelsolin inhibits apoptosis by blocking mitochondrial membrane potential loss and cytochrome c release.

Authors:  R C Koya; H Fujita; S Shimizu; M Ohtsu; M Takimoto; Y Tsujimoto; N Kuzumaki
Journal:  J Biol Chem       Date:  2000-05-19       Impact factor: 5.157

Review 2.  Chagas disease.

Authors:  Anis Rassi; Anis Rassi; José Antonio Marin-Neto
Journal:  Lancet       Date:  2010-04-17       Impact factor: 79.321

3.  Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle.

Authors:  K Poetter; H Jiang; S Hassanzadeh; S R Master; A Chang; M C Dalakas; I Rayment; J R Sellers; L Fananapazir; N D Epstein
Journal:  Nat Genet       Date:  1996-05       Impact factor: 38.330

Review 4.  Chagas disease: Present status of pathogenic mechanisms and chemotherapy.

Authors:  Juan Diego Maya; Myriam Orellana; Jorge Ferreira; Ulrike Kemmerling; Rodrigo López-Muñoz; Antonio Morello
Journal:  Biol Res       Date:  2010-11-30       Impact factor: 5.612

5.  Aberrant profiles of native and oxidized glycoproteins in Alzheimer plasma.

Authors:  Han-Ling Yu; Howard M Chertkow; Howard Bergman; Hyman M Schipper
Journal:  Proteomics       Date:  2003-11       Impact factor: 3.984

6.  Tissue-specific oxidative imbalance and mitochondrial dysfunction during Trypanosoma cruzi infection in mice.

Authors:  Jian-Jun Wen; Monisha Dhiman; Elbert B Whorton; Nisha Jain Garg
Journal:  Microbes Infect       Date:  2008-07-16       Impact factor: 2.700

7.  An estimate of the burden of Chagas disease in the United States.

Authors:  Caryn Bern; Susan P Montgomery
Journal:  Clin Infect Dis       Date:  2009-09-01       Impact factor: 9.079

8.  Trypanosoma cruzi DNA in cardiac lesions of Argentinean patients with end-stage chronic chagas heart disease.

Authors:  Alejandro G Schijman; Carlos A Vigliano; Rodolfo J Viotti; Juan M Burgos; Silvia Brandariz; Bruno E Lococo; Maria I Leze; Hector A Armenti; Mariano J Levin
Journal:  Am J Trop Med Hyg       Date:  2004-02       Impact factor: 2.345

9.  Mitochondrial generation of reactive oxygen species is enhanced at the Q(o) site of the complex III in the myocardium of Trypanosoma cruzi-infected mice: beneficial effects of an antioxidant.

Authors:  Jian-Jun Wen; Nisha Jain Garg
Journal:  J Bioenerg Biomembr       Date:  2008-11-14       Impact factor: 2.945

10.  [Not Available].

Authors:  Shivali Gupta; Jian-Jun Wen; Nisha Jain Garg
Journal:  Interdiscip Perspect Infect Dis       Date:  2009-06-14
View more
  7 in total

1.  Innate immune responses and antioxidant/oxidant imbalance are major determinants of human Chagas disease.

Authors:  Monisha Dhiman; Yun A Coronado; Cecilia K Vallejo; John R Petersen; Adetoun Ejilemele; Sonia Nuñez; Maria Paola Zago; Heidi Spratt; Nisha Jain Garg
Journal:  PLoS Negl Trop Dis       Date:  2013-08-08

2.  Vitamin D-binding protein controls T cell responses to vitamin D.

Authors:  Martin Kongsbak; Marina Rode von Essen; Trine Bøegh Levring; Peter Schjerling; Anders Woetmann; Niels Ødum; Charlotte Menné Bonefeld; Carsten Geisler
Journal:  BMC Immunol       Date:  2014-09-18       Impact factor: 3.615

3.  Vimentin and Anti Vimentin Antibodies in Chagas' Disease.

Authors:  Marilda Savoia Nascimento; Anna Maria Simonsen Stolf; Heitor Franco de Andrade Junior; Ramendra Pati Pandey; Eufrosina Setsu Umezawa
Journal:  Arq Bras Cardiol       Date:  2018-03-12       Impact factor: 2.000

4.  Molecular dissection of Chagas induced cardiomyopathy reveals central disease associated and druggable signaling pathways.

Authors:  Jacob M Wozniak; Tatiana Araújo Silva; Diane Thomas; Jair L Siqueira-Neto; James H McKerrow; David J Gonzalez; Claudia M Calvet
Journal:  PLoS Negl Trop Dis       Date:  2020-05-20

Review 5.  Potential Role of Antioxidants as Adjunctive Therapy in Chagas Disease.

Authors:  Juana P Sánchez-Villamil; Paula K Bautista-Niño; Norma C Serrano; Melvin Y Rincon; Nisha J Garg
Journal:  Oxid Med Cell Longev       Date:  2020-03-26       Impact factor: 6.543

Review 6.  Plasma Gelsolin: Indicator of Inflammation and Its Potential as a Diagnostic Tool and Therapeutic Target.

Authors:  Ewelina Piktel; Ilya Levental; Bonita Durnaś; Paul A Janmey; Robert Bucki
Journal:  Int J Mol Sci       Date:  2018-08-25       Impact factor: 5.923

7.  Prognostic Performance of Peripheral Blood Biomarkers in Identifying Seropositive Individuals at Risk of Developing Clinically Symptomatic Chagas Cardiomyopathy.

Authors:  Subhadip Choudhuri; Suresh K Bhavnani; Weibin Zhang; Valentina Botelli; Natalia Barrientos; Facundo Iñiguez; Maria Paola Zago; Nisha Jain Garg
Journal:  Microbiol Spectr       Date:  2021-08-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.